Catalyst Wire Dossier Catalyst Wire Dossier

Teduglutide (Revestive)

teduglutide · Takeda
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Teduglutide (Revestive), covering 2025-04-06 to 2025-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada

See pricing